The role of Y1 receptors in regulating food intake

Drugs of the Future

Volumn 27, Issue 6, 2002, Pages 589-595

  Kanatani, Akio ^a   Ishihara, Akane ^a   Fukami, Takehiro ^a   Ihara, Masaki ^a  

^a BANYU PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

383 U 91; APPETITE STIMULANT; BMS 193885; CP 671906; GR 231118; LY 357897; N2 DIPHENYLACETYL N (4 UREIDOMETHYLBENZYL)ARGININAMIDE; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y1 RECEPTOR BLOCKING AGENT; NGD 95 1; PURINE DERIVATIVE; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG STRUCTURE; FOOD INTAKE; HOMEOSTASIS; RECEPTOR DOWN REGULATION; REVIEW;

EID: 0036620757     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2002.027.06.680240     Document Type: Review

References (71)

1. Tatemoto, K., Carlquist, M., Mutt, V. Neuropeptide Y - a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 1982, 296: 659-60.
2. Clark, J.T., Kalra, P.S., Crowley, W.R., Kalra, S.P. Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology 1984, 115: 427-9.
3. Stanley, B.G., Leibowitz, S.F. Neuropeptide Y: Stimulation of feeding and drinking by injection into the paraventricular nucleus. Life Sci 1984, 35: 2635-42.
4. Stanley, B.G., Kyrkouli, S.E., Lampert, S., Leibowitz, S.F. Neuropeptide Y chronically injected into the hypothalamus: A powerful neurochemical inducer of hyperphagia and obesity. Peptides 1986, 7: 1189-92.
5. Zarjevski, N., Cusin, I., Vettor, R. et al. Chronic intracerebroventricular neuropeptide Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology 1993, 133: 1753-8.
6. Erikson, J.C., Hollopeter, G., Palmiter, R.D. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science 1996, 274: 1704-7.
7. Herzog, H., Hort, Y.J., Ball, H.J. et al. Cloned human neuropeptide Y receptor couples to two different second messenger systems. Proc Natl Acad Sci USA 1992, 89: 5794-8.
8. 1 type. J Biol Chem 1992, 267: 10935-8.
9. 1 subtype pharmacology of a recombinantly expressed neuropeptide receptor. Mol Pharmacol 1992, 41: 817-21.
10. Eva, C., Obrerto, A., Sprengel, R., Genazzani, E. The murine NPY-1 receptor gene-structure and delineation of tissue-specific expression. FEBS Lett 1992, 314: 285-8.
11. Rose, P.M., Fernandes, P., Lynch, J.S. et al. Cloning and functional expression of a cDNA encoding a human type 2 neuropeptide Y receptor. J Biol Chem 1995, 270: 22661-4.
12. 2 receptor subtype. J Biol Chem 1995, 270: 26758-61.
13. 2 receptor. Mol Pharmacol 1996, 49: 224-8.
14. 4 subtype receptor for pancreatic polypeptide, neuropeptide Y, peptide YY. J Biol Chem 1995, 270: 26762-5.
15. Lundell, I., Blomqvist, A.G., Berglund, M.M. et al. Cloning a human receptor of the NPY receptor family with high affinity for pancreatic potypeptide and peptide YY. J Biol Chem 1995, 270: 29123-8.
16. Gregor, P., Millham, M.L., Feng, Y. et al. Cloning and characterization of a novel receptor to pancreatic polypeptide, a member of the neuropeptide Y receptor family. FEBS Lett 1996, 381: 58-62.
17. Gerald, C., Walker, M.W., Criscione, L. et al. A receptor subtype involved in neuropeptide Y-induced food intake. Nature 1996, 382: 168-71.
18. Hu, Y., Bloomquist, B.T., Cornfield, L.J. et al. Identification of a novel hypothalamic neuropeptide Y receptor associated with feeding behavior. J Biol Chem 1996, 271: 26315-9.
19. Weinberg, D.H., Sirinathsinghji, D.J.S, Tan, C.P. et al. Cloning and expression of a novel neuropeptide Y receptor. J Biol Chem 1996, 271: 16435-8.
20. Matsumoto, M., Nomura, T., Momose, K., et al. Inactivation of a novel neuropeptide Y peptide YY receptor gene in primate species. J Biol Chem 1996, 271: 27217-20.
21. Gregor, P., Feng, Y., DeCarr, L.B. et al. Molecular characterization of a second mouse pancreatic polypeptide receptor and its inactivated human homologue. J Biol Chem 1996, 271: 27776-81.
22. 5 neuropeptide Y receptor in feeding and obesity. Nat Med 1998, 4: 718-21.
23. 1 receptor. Nat Med 1998, 4: 722-6.
24. Inui, A. Neuropeptide Y feeding receptors: Are multiple subtypes involved? A review. TIPS 1999, 20: 43-6.
25. 5 receptor deficient mice. Endocrinology 2000, 141: 1011-6.
26. Daniels, A.J., Matthews, J.E., Slepetis, R.J. et al. High-affinity neuropeptide Y receptor antagonists. Proc Natl Acad Sci USA 1995, 92: 9067-71.
27. 1 receptor antagonist, 1229U91: Blockade of neuropeptide Y-induced and physiological food intake. Endocrinology 1996, 137: 3177-82.
28. 1 antagonists. J Med Chem 1997, 40: 3712-14.
29. 1-like receptor in rodents. Regul Pept 1998, 75-76: 409-15.
30. 1 selective antagonist BIBP3226. Br J Pharmacol 1998, 124: 1507-15.
31. 1 receptor antagonist BIBO 3304 and its effect on feeding in rodents. Br J Pharmacol 1998, 125: 549-55.
32. 1 receptor antagonist J-104870: A potent feeding suppressant with oral bioavailability. Biochem Biophys Res Commun 1999, 268: 88-91.
33. 1 receptor antagonists. Bioorg Med Chem Lett 2002, 12: 379-82.
34. 5 receptor in food intake in rats. 6th Int NPY Conf (Apr 22-26, Sydney) 2001, Abst O.11.
35. 1 antagonist. 6th Int NPY Conf (Apr 22-26, Sydney) 2001, Abst O.43.
36. 1 antagonist, J-115814. Mol Pharmacol 2001, 59: 501-5.
37. Wahlestedt, C., Yanaihara, N., Hakanson, R. Evidence for different pre- and post-junctional receptors for neuropeptide Y and related peptides. Regul Pept 1986, 13: 307-318.
38. 1 receptor agonist. Proc Natl Acad Sci USA 1990, 87: 182-86.
39. Grundemar, L., Hakanson, R. Neuropeptide Y effector systems: Perspectives for drug development: A review. TIPS 1994, 15: 153-9.
40. 2 receptor effects on natural meal patterns. Peptides 1991, 12: 1251-60.
41. Kalra, S.P., Dube, M.G., Fournier, A., Kalra, P.S. Structure-function analysis of stimulation of food intake by neuropeptide Y: Effects of receptor agonists. Physiol Behav 1991, 50: 5-9.
42. 1 receptor agonists with orexigenic activity in vivo. Mol Pharmacol 2001, 60: 534-40.
43. 1 receptors potently stimulates food intake in male rhesus monkeys. J Clin Endocrinol Metab 1999, 84: 3781-91.
44. 1 receptor antagonist: BIBP3226. Eur J Pharmacol 1994, 271: R11-3.
45. 1 receptor antagonist BIBP3226 blocks NPY induced feeding via a nonspecific mechanism. Regul Pept 1998, 75-76: 377-82.
46. 1 receptor antagonists. Bioorg Med Chem Lett 1999, 9: 647-52.
47. 5 receptors in feeding behavior. 6th Int NPY Conf (Apr 22-26, Sydney) 2001, Abst O.44.
48. 5 receptor antagonist. Biochem Biophys Res Commun 2000, 272: 169-73.
49. 5 receptors in the developing and adult mouse nervous system. Neuroscience 1998, 87: 289-302.
50. Zhang, Y., Proenca, R., Maffei, M. et al. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372: 425-32.
51. Chua, S.C. Jr., Chung, W.K., Wu-Peng, X.S. et al. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science 1996, 271: 994-6.
52. Montague, C.T., Farooqi, I.S., Whitehead, J.P. et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997, 387: 903-8.
53. Beck, B., Burlet, A., Nicolas, J.P., Burlet, C. Hypothalamic neuropeptide Y in obese Zucker fatty rats: Implications in feeding and sexual behaviors. Physiol Behav 1990, 47: 449-53.
54. Stephens, T.W., Basinski, M., Bristow, P.K. et al. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 1995, 377: 530-2.
55. Ishihara, A., Tanaka, T., Kanatani, A. et al. A potent neuropeptide Y antagonist, 1229U91, suppressed spontaneous food intake in Zucker fatty rats. Am J Physiol 1998, 43: R1500-4.
56. Krude, H., Biebermann, H., Luck, W. et al. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 1998, 19: 155-7.
57. Jackson, R.S., Creemers, J.W., Ohagi, S. et al. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat Genet 1997, 16: 303-6.
58. Yeo, G.S.H., Farooqi, I.S., Aminian, S. er al. A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat Genet 1998, 20: 111-2.
59. Vaisse, C., Clement, K., Guy-Grand, B., Froguel, P. A frameshift mutation in human MC4R is associated with a dominant form obesity. Nat Genet 1998, 20: 113-4.
60. Kask, A., Rago, L., Korrovits, P. et al. Evidence that orexigenic effects of melanocortin 4 receptor antagonist HS014 are mediated by neuropeptide Y. Biochem Biophys Res Commun 1998, 248: 245-9.
61. 1 receptor antagonists. Can J Physiol Pharmacol 2000, 78: 143-9.
62. 1 receptor pathway. Diabetes 2001, 50: 227-32.
63. Asakawa, A., Inui, A., Kaga, T. et al. Ghrelin is an appetitestimulatory signal from stomach with structural resemblance to motilin. Gastorenterology 2001, 120: 337-45.
64. 1 receptors are involved in stimulation of feeding by orexins (hypocretins) in sated rats. Regul Pept 2000, 87: 19-24.
65. Yamanaka, A., Kunii, K., Nambu, T. et al. Orexin-induced food intake involves neuropeptide Y pathway. Brain Res 2000, 859: 404-9.
66. 1-receptor in the rat. Endocrinology 2002, 143: 191-7.
67. Neurogen halts obesity trial. SCRIP 1997, 2294: 25.
68. 1 receptor blockade by AR-H040922. 6th Int NPY Conf (Apr 22-26, Sydney) 2001, Abst O.42.
69. Levitsky, D.A., Strupp, B.J., Lupoli, J. Tolerance to anorectic drugs: Pharmacological or artifactual. Pharmacol Biochem Behav 1980, 14: 661-7.
70. Lewander, T.A. A mechanism for the development of tolerance to amphetamine in rats. Psychopharmacologia 1971, 21, 17-31.
71. 1 antagonist. Br J Pharmacol 2002, 136: 341-6.